Search clinical trials for: Fluorouracil

Total 1852 results

McGill University

Unknown

Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Gastric Junction Adenocarcinoma

Canada
Pfizer

Terminated

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Neoplasm Metastasis | Colorectal Neoplasms

United States
Mast Therapeutics, Inc.

Completed

Clinical Trial in Patients With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer

United Kingdom, Serbia, India, Poland, Romania
National Taiwan University Hospital

Terminated

Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer

Gastric Cancer

Taiwan
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer

Esophageal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer

Breast Cancer

France
Stony Brook University

Unknown

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

United States
Shahid Beheshti University of Medical Sciences

Unknown

Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure

Bleb

Iran, Islamic Republic of
Dana-Farber Cancer Institute
Massachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Brigham...

Completed

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma | Carcinoma of Head and/or Neck

United States
Dana-Farber Cancer Institute
Sanofi; Brigham and Women's Hospital

Completed

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of Head and Neck | Advanced Squamous Cell Carcinoma | SSCHN
Dana-Farber Cancer Institute
Massachusetts General Hospital; Sanofi; Brigham and Women's Hospital

Completed

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma | Carcinoma of Head/Neck

United States
Mast Therapeutics, Inc.

Unknown

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

Breast Cancer

Argentina, Mexico, Peru, Russian Federation, Spain
Sanofi

Completed

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

Actinic Keratoses

United States
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown

Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Hepatocellular Carcinoma

China
Sanofi

Completed

A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

Stomach Neoplasms

Colombia
National Institute of Diabetes and Digestive and...

Completed

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Neoplasm Metastasis | Zollinger Ellison Syndrome | Islet Cell Adenoma

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer

Colorectal Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

Breast Cancer | Breast Neoplasms

United States
Pfizer

Completed

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Colorectal Neoplasms

United States, Canada
University of North Carolina
General Mills

Completed

Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms

Pain

United States
Sanofi

Completed

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

France
Sanofi

Completed

Endometrial Cancer - LOHP Alone and With 5FU

Endometrial Cancer

France
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Breast Cancer

Greece
Peking University
Fudan University; Capital Medical University

Unknown

Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer

Stomach Neoplasms | Gastric Cancer

China
Indiana University School of Medicine

Completed

Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C

Glaucoma

United States
Mast Therapeutics, Inc.

Unknown

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Former Serbia and Montenegro
Ministry of Scientific Research and Information...

Terminated

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Esophageal Neoplasms | Squamous Cell Cancer

Poland
Southwestern Regional Medical Center

Terminated

ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

United States
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Suspended

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Japan
National Taiwan University Hospital

Completed

Weekly TP-HDFL in the Treatment of Advanced TCC

Transitional Cell Carcinoma

Taiwan
National Taiwan University Hospital

Completed

A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers

Recurrent or Metastatic Colorectal Cancer

Taiwan
Finnish Breast Cancer Group
Sanofi; Hoffmann-La Roche; AstraZeneca

Completed

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

Breast Cancer

Finland
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Taiwan
Seattle Cancer Treatment and Wellness Center

Unknown

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Stage III Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Adenocarincoma of Pancreas

United States
Eisai Limited

Completed

An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin

Colorectal Cancer

United Kingdom, France
National Cancer Institute (NCI)

Completed

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors

Neoplasms | Lymphoma

United States
Chiron Corporation

Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Adenocarcinoma | Stomach Neoplasms | Esophageal Neoplasms

United States
Hokkaido Gastrointestinal Cancer Study Group

Terminated

Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Japan
Austrian Breast & Colorectal Cancer Study Group

Terminated

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Rectal Cancer Dukes B, Dukes C

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
European Institute of Oncology

Completed

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Carcinoma | Breast Neoplasms
OSI Pharmaceuticals

Completed

A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Locally Advanced or Metastatic Adenoca of the Biliary Tract

United States, Belgium, Germany, Poland, Romania, Switzerland
Hokkaido Gastrointestinal Cancer Study Group

Completed

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Japan
Odense University Hospital

Completed

Patients Preference for Oral or i.v. Therapy

Colorectal Cancer

Denmark
Association Européenne de Recherche en Oncologie
Pfizer; Aventis Pharmaceuticals

Unknown

5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer

Cancer of the Rectum

France
Association Européenne de Recherche en Oncologie
Bristol-Myers Squibb

Unknown

6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer

Breast Cancer

3

Subscribe